Research InterestsDr. Kotloff is a lead investigator at the Vaccine and Treatment Evaluation Unit VTEU in the Center for Vaccine Development at the University of Maryland School of Medicine, which is leading one of the nation’s first studies of an experimental vaccine designed to prevent the 2009 H1N1 influenza virus (see news release). Dr. Kotloff also conducts Phase 1 and 2 clinical trials in adults of vaccines for the prevention of Shigella, group A streptococcus, Helicobacter pylori and other infectious diseases. She also runs clinical trials of pediatric vaccines. She has conducted several large epidemiologic studies to study infantile diarrhea and sexually transmitted diseases (including HIV) among college students. She has recently begun designing studies of the epidemiology of group A streptococcus, diarrheal diseases and several vaccine-preventable infections in Bamako, Mali, in collaboration with local researchers at CVD - Mali. Publications
Tapia M., Sow S., Medina-Moreno S., Lim Y., Pasetti M., Kotloff K., Levine M.M. A serosurvey to identify the "window of vulnerability" to wild type measles among infants in rural Mali. Am J Trop Med Hyg 2005;73:26-31. |
